Ariad Pharmaceuticals Inc fka ARIA

[jaybe]

I'm around but as Dough says I'm a bit sidelined by spotty wifi in various EU countries. I'm reading all posts but unable to research in support of any novel contributions. From what I'm reading you guys are killing it anyway.

Must admit I was hoping for 70%+ response rate in Criz resist. but I'll take the 100% in Criz naive as a consolation. I think Jesspro and others are right that BIC will now come down to duration of response.

Brain met activity should bump up the Ariad target pool of 14,000 by another 6,000 or so, basically all stage 3-4 ALK+ pts. with or without BM. And we can add back in the 2L failures due to BM from LDK and Alectinib and soon ROS1 and I think '113 could target 30,000+ patients a year.